168 related articles for article (PubMed ID: 17052977)
1. Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
J Biol Chem; 2006 Dec; 281(50):38448-58. PubMed ID: 17052977
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions.
Chappell KJ; Nall TA; Stoermer MJ; Fang NX; Tyndall JD; Fairlie DP; Young PR
J Biol Chem; 2005 Jan; 280(4):2896-903. PubMed ID: 15494419
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis of D80-82 and G83 residues in West Nile Virus NS2B: effects on NS2B-NS3 activity and viral replication.
Jia F; Fan J; Zhang B; Yuan Z
Virol Sin; 2013 Feb; 28(1):16-23. PubMed ID: 23325418
[TBL] [Abstract][Full Text] [Related]
4. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.
Nall TA; Chappell KJ; Stoermer MJ; Fang NX; Tyndall JD; Young PR; Fairlie DP
J Biol Chem; 2004 Nov; 279(47):48535-42. PubMed ID: 15322074
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
9. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.
Shiryaev SA; Kozlov IA; Ratnikov BI; Smith JW; Lebl M; Strongin AY
Biochem J; 2007 Feb; 401(3):743-52. PubMed ID: 17067286
[TBL] [Abstract][Full Text] [Related]
10. NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease.
Su XC; Ozawa K; Qi R; Vasudevan SG; Lim SP; Otting G
PLoS Negl Trop Dis; 2009 Dec; 3(12):e561. PubMed ID: 19997625
[TBL] [Abstract][Full Text] [Related]
11. Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase.
Radichev I; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
J Gen Virol; 2008 Mar; 89(Pt 3):636-641. PubMed ID: 18272753
[TBL] [Abstract][Full Text] [Related]
12. Yellow fever virus NS3 protease: peptide-inhibition studies.
Löhr K; Knox JE; Phong WY; Ma NL; Yin Z; Sampath A; Patel SJ; Wang WL; Chan WL; Rao KRR; Wang G; Vasudevan SG; Keller TH; Lim SP
J Gen Virol; 2007 Aug; 88(Pt 8):2223-2227. PubMed ID: 17622626
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
14. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
[TBL] [Abstract][Full Text] [Related]
15. West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
[TBL] [Abstract][Full Text] [Related]
16. Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis.
Shiryaev SA; Ratnikov BI; Aleshin AE; Kozlov IA; Nelson NA; Lebl M; Smith JW; Liddington RC; Strongin AY
J Virol; 2007 May; 81(9):4501-9. PubMed ID: 17301157
[TBL] [Abstract][Full Text] [Related]
17. Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase.
Shiryaev SA; Ratnikov BI; Chekanov AV; Sikora S; Rozanov DV; Godzik A; Wang J; Smith JW; Huang Z; Lindberg I; Samuel MA; Diamond MS; Strongin AY
Biochem J; 2006 Jan; 393(Pt 2):503-11. PubMed ID: 16229682
[TBL] [Abstract][Full Text] [Related]
18. Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.
Tomlinson SM; Watowich SJ
Biochemistry; 2008 Nov; 47(45):11763-70. PubMed ID: 18855422
[TBL] [Abstract][Full Text] [Related]
19. West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy.
Gayen S; Chen AS; Huang Q; Kang C
Biochem Biophys Res Commun; 2012 Jul; 423(4):799-804. PubMed ID: 22713461
[TBL] [Abstract][Full Text] [Related]
20. Unexpected similarity between the cytosolic West Nile virus NS3 and the secretory furin-like serine proteinases.
Seidah NG
Biochem J; 2006 Jan; 393(Pt 2):e1-3. PubMed ID: 16371006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
